Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways-Reference-Cited by-同舟云学术

Small Molecule R1498 as a Well-Tolerated and Orally Active Kinase Inhibitor for Hepatocellular Carcinoma and Gastric Cancer Treatment via Targeting Angiogenesis and Mitosis Pathways

Published:2013-06-05 Issue:6 Volume:8 Page:e65264
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Zhang Chao,Wu Xihan,Zhang Meifang,Zhu Liangcheng,Zhao Rong,Xu Danqing,Lin Zhaohu,Liang Chungen,Chen Taiping,Chen Li,Ren Yi,Zhang Joe,Qin Ning,Zhang Xiongwen

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference31 articles.

1. Strategies for optimizing combinations of molecularly targeted anticancer agents;JE Dancey;Nat Rev Drug Discov,2006

2. Sorafenib in advanced hepatocellular carcinoma;JM Llovet;N Engl J Med,2008

3. Sorafenib for treatment of hepatocellular carcinoma: a systematic review;B Xie;Dig Dis Sci,2012

4. Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial;YJ Bang;Lancet,2010

5. Trastuzumab: triumphs and tribulations;R Nahta;Oncogene,2007

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges;Molecules;2022-08-28

2. Aurora kinase: An emerging potential target in therapeutics;Protein Kinase Inhibitors;2022

3. Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy;Molecular Cancer;2021-01-15

4. Biological effects of corosolic acid as an anti‑inflammatory, anti‑metabolic syndrome and anti‑neoplasic natural compound (Review);Oncology Letters;2020-12-02

5. Targeting high Aurora kinases expression as an innovative therapy for hepatocellular carcinoma;Oncotarget;2017-03-02